Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma

Hepatobiliary and Pancreatic Diseases International

Volumn 14, Issue 2, 2015, Pages 178-185

  Wang, Zhong Xia ^a   Jiang, Chun Ping ^a,b   Cao, Yin ^a   Zhang, Guang ^b   Chen, Wei Bo ^a   Ding, Yi Tao ^a,b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

hepatectomy; hepatocellular carcinoma; liver enzyme; recurrence; resection

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE; LIVER ENZYME; HYDROLYASE; LACTATE DEHYDRATASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CHEMISTRY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CHEMICAL PARAMETERS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HAZARD RATIO; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; RECURRENCE FREE SURVIVAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; SURGICAL PATIENT; TUMOR RECURRENCE; UNIVARIATE ANALYSIS; AREA UNDER THE CURVE; BLOOD; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS; METABOLISM; MINIMAL RESIDUAL DISEASE; PATHOLOGY; RETROSPECTIVE STUDY; SECONDARY; TIME FACTOR;

ADULT; AGED; ALANINE TRANSAMINASE; ALPHA-FETOPROTEINS; AREA UNDER CURVE; ASPARTATE AMINOTRANSFERASES; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HUMANS; HYDRO-LYASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PREOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; TIME FACTORS;

EID: 84941904533     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(15)60353-8     Document Type: Article

References (33)

1. A Jemal, F Bray, MM Center, J Ferlay, E Ward, D Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. ST Fan, CM Lo, CL Liu, CM Lam, WK Yuen, C Yeung et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths Ann Surg 229 1999 322 330
3. RT Poon, ST Fan, CM Lo, CL Liu, J Wong Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation Ann Surg 235 2002 373 382
4. RT Poon, ST Fan, IO Ng, CM Lo, CL Liu, J Wong Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma Cancer 89 2000 500 507
5. N Portolani, A Coniglio, S Ghidoni, M Giovanelli, A Benetti, GA Tiberio et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications Ann Surg 243 2006 229 235
6. JM Chun, HJ Kwon, J Sohn, SG Kim, JY Park, HI Bae et al. Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma J Surg Oncol 103 2011 148 151
7. C Cha, Y Fong, WR Jarnagin, LH Blumgart, RP DeMatteo Predictors and patterns of recurrence after resection of hepatocellular carcinoma J Am Coll Surg 197 2003 753 758
8. J Yamamoto, T Kosuge, T Takayama, K Shimada, S Yamasaki, H Ozaki et al. Recurrence of hepatocellular carcinoma after surgery Br J Surg 83 1996 1219 1222
9. N Nagasue, M Uchida, Y Makino, Y Takemoto, A Yamanoi, T Hayashi et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma Gastroenterology 105 1993 488 494
10. ZG Du, YG Wei, KF Chen, B Li Risk factors associated with early and late recurrence after curative resection of hepatocellular carcinoma: a single institution's experience with 398 consecutive patients Hepatobiliary Pancreat Dis Int 13 2014 153 161
11. JM Llovet, C Brú, J Bruix Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 1999 329 338
12. A Forner, ME Reig, CR de Lope, J Bruix Current strategy for staging and treatment: the BCLC update and future prospects Semin Liver Dis 30 2010 61 74
13. M Shimada, K Takenaka, T Gion, Y Fujiwara, K Kajiyama, T Maeda et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan Gastroenterology 111 1996 720 726
14. RT Poon, ST Fan, CM Lo, CL Liu, J Wong Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors Ann Surg 229 1999 216 222
15. H Imamura, Y Matsuyama, E Tanaka, T Ohkubo, K Hasegawa, S Miyagawa et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy J Hepatol 38 2003 200 207
16. T Li, LX Qin, X Gong, J Zhou, HC Sun, L Wang et al. Clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence of female patients after curative resection of hepatocellular carcinoma Surgery 156 2014 651 660
17. HW Hann, S Wan, RE Myers, RS Hann, J Xing, B Chen et al. Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients PLoS One 7 2012 e47687
18. YJ Lin, MH Lee, HI Yang, CL Jen, SL You, LY Wang et al. Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients PLoS One 8 2013 e61448
19. D Capece, M Fischietti, D Verzella, A Gaggiano, G Cicciarelli, A Tessitore et al. The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages Biomed Res Int 2013 2013 187204
20. YF Han, J Zhao, LY Ma, JH Yin, WJ Chang, HW Zhang et al. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma World J Gastroenterol 17 2011 4258 4270
21. EG Giannini, G Sammito, F Farinati, F Ciccarese, A Pecorelli, GL Rapaccini et al. Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use Cancer 120 2014 2150 2157
22. I Makino, K Chijiiwa, K Kondo, J Ohuchida, M Kai Prognostic benefit of selective portal vein occlusion during hepatic resection for hepatocellular carcinoma Surgery 137 2005 626 631
23. SC Katz, J Shia, KH Liau, M Gonen, L Ruo, WR Jarnagin et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma Ann Surg 249 2009 617 623
24. K Hasegawa, N Kokudo Surgical treatment of hepatocellular carcinoma Surg Today 39 2009 833 843
25. Y Fujiwara, K Takenaka, K Kajiyama, T Maeda, T Gion, K Shirabe et al. The characteristics of hepatocellular carcinoma with a high level of serum lactic dehydrogenase: a case report Hepatogastroenterology 44 1997 820 823
26. N Kohles, D Nagel, D Jüngst, J Durner, P Stieber, S Holdenrieder Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy Tumour Biol 33 2012 33 40
27. M Scartozzi, L Faloppi, M Bianconi, R Giampieri, E Maccaroni, A Bittoni et al. The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management PLoS One 7 2012 e32653
28. L Faloppi, M Scartozzi, M Bianconi, G Svegliati Baroni, P Toniutto, R Giampieri et al. The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management BMC Cancer 14 2014 110
29. O Warburg On the origin of cancer cells Science 123 1956 309 314
30. EG Giannini, R Testa, V Savarino Liver enzyme alteration: a guide for clinicians CMAJ 172 2005 367 379
31. H Cichoż-Lach, K Celiński, B Prozorow-Król, J Swatek, M Słomka, T Lach The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease Med Sci Monit 18 2012 CR735 CR740
32. H Shijo, M Okazaki Prediction of portal vein invasion by hepatocellular carcinoma: a correlations between portal vein tumor thrombus and biochemical tests Jpn J Clin Oncol 21 1991 94 99
33. Y Yamashita, K Shirabe, T Toshima, E Tsuijita, K Takeishi, N Harimoto et al. Risk factors for recurrence after curative resection of hepatitis C-related hepatocellular carcinoma in patients without postoperative interferon therapy Hepatol Res 43 2013 1313 1320